Cancer cells present new surface antigens that are recognized by the immune system as exogenous or “not-self,” leading to cancer cell recognition by antigen-presenting cells (APCs), immune activation, and facilitation of cancer cell elimination by CD8+ cytotoxic T-lymphocytes (CTLs). The gene discussed is CD8A; the disease is cancer.